![Christopher Lai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 278 M $ au 31/05/2026
Christopher Lai was the founder of AquaFresco, Inc., founded in 2015, and held the title of Chief Technology Officer.
Dr. Lai is the founder of Metis Pharmaceuticals, founded in 2019, and holds the titles of General Manager and Executive Director.
Dr. Lai is the founder of Metis TechBio Co., Ltd., founded in 2020, and holds the titles of Chairman and Chief Executive Officer.
Dr. Lai is also the founder of METiS Therapeutics, Inc...
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/05/2026 | 111 166 572 ( 10,56% ) | 210 M $ | 31/05/2026 | |
METIS TECHBIO CO., LTD. 36,55% | 13/05/2026 | 36 400 278 ( 36,55% ) | 69 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| METIS TECHBIO CO., LTD. | Directeur Général | 10/01/2020 |
METiS Therapeutics, Inc.
 METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Directeur Général | - |
Metis Pharmaceuticals
 Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Provides an artificial intelligence-driven drug formulation platform | Fondateur | 01/01/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
AquaFresco, Inc.
 AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
AquaFresco, Inc.
AquaFresco, Inc. Industrial MachineryProducer Manufacturing Designs and develops water recycling technology | Producer Manufacturing |
Metis Pharmaceuticals
Metis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Provides an artificial intelligence-driven drug formulation platform | Health Technology |
METiS Therapeutics, Inc.
METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Health Technology |
Hangzhou Jitai Pharmaceutical Technology Co. Ltd.
 Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Chemicals: Major DiversifiedProcess Industries Operates as an investment holding company whose subsidiaries provides AI based nanomaterials delivery and application services | Process Industries |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
